The British Generic Manufacturers Association (BGMA) has welcomed Tim de Gavre as its new chair - a role he will hold for the next two years.

Tim replaces Peter Ballard, who will serve a further year as vice-chair of the association, which is the representative organisation for generic medicine manufacturers in the UK.

A former chair of the British Biosimilars Association (BBA) - the sister association to the BGMA - Tim is head of Sandoz UK.  Tim has worked for Sandoz since 2010 holding a series of leadership roles in biosimilars and generics.  Prior to joining Sandoz, Tim worked as a consultant at McKinsey & Company and in healthcare venture capital with Frazier Healthcare Ventures.